NBR1 and neoplasm: In oesophageal cancer, the LINC01592/E2F6/NBR1/MHC‐I axis enhances MHC‐I degradation in autophagolysosomes and reduces its surface expression on cancer cells, facilitating immune evasion by CD8+ CTLs and promoting tumour progression.74